Sign Up Today and Learn More About Alamar Biosciences Stock
Invest in or calculate the value of your shares in Alamar Biosciences or other pre-IPO companies through EquityZen's platform.
Alamar Biosciences Stock (ALAB)
Alamar Biosciences develops technologies for the detection and treatment of cancer and other diseases at the earliest possible time.
About Alamar Biosciences Stock
Founded
2018
Headquarters
Fremont, CA, US
Industries
Science and Engineering, Health Care, Biotechnology
Alamar Biosciences Press Mentions
Stay in the know about the latest news on Alamar Biosciences
Attovia Building Immune-Mediated Disease Pipeline with $90M Series C
genengnews • Apr 15, 2025
Nucleic acid linked immune-sandwich assay (NULISA)
patents • Apr 02, 2025
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
prnewswire • Mar 26, 2025
Alamar Biosciences Announces First Five Distribution Partners, Expanding Commercial Support in Asia Pacific
prnewswire • Mar 19, 2025
Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers
biospace • Feb 21, 2025
Alamar Biosciences Management
Leadership team at Alamar Biosciences
Chief Medical Officer
Mike Nerenberg
Chief Technology Officer
Xiao-Jun Ma
Join now and verify your accreditation status to gain access to:
- Alamar Biosciences Current Valuation
- Alamar Biosciences Stock Price
- Alamar Biosciences Management
- Available deals in Alamar Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Alamar Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Alamar Biosciences Revenue and Financials
- Alamar Biosciences Highlights
- Alamar Biosciences Business Model
- Alamar Biosciences Risk Factors
- Alamar Biosciences Research Report from SACRA Research
Trading Alamar Biosciences Stock
How to invest in Alamar Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Alamar Biosciences through EquityZen funds. These investments are made available by existing Alamar Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Alamar Biosciences stock?
Shareholders can sell their Alamar Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
